UBX - Unity Biotechnology files for $125M mixed shelf offering; shares up 19%

Unity Biotechnology (NASDAQ:UBX) has filed for a $125M mixed shelf offering. Shares are up 19% in after-hours trading. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company said it will explain the use of proceeds in a prospectus supplement. The offering can include common stock, preferred stock, debt securities, units and warrants. Unity (UBX) reported Q4 2021 results Tuesday morning.

For further details see:

Unity Biotechnology files for $125M mixed shelf offering; shares up 19%